Empirical Finance’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Empirical Finance's WST Position: Q3 2026 in Review
Empirical Finance increased its West Pharmaceutical (WST) stake by 2.2% in Q3 2026, buying an estimated $19.1K and bringing the position to 2,555 shares worth $947K. The position accounts for 0.04% of the portfolio, ranked #332.
Empirical Finance first reported a position in WST in Q2 2021 and has held it in 22 quarters since. The position peaked at $992K in Q1 2024. 875 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Empirical Finance held 2,555 shares of West Pharmaceutical worth $947K as of Q3 2026.
- Empirical Finance bought 54 West Pharmaceutical shares in Q3 2026, an estimated $19.1K.
- West Pharmaceutical made up 0.04% of Empirical Finance's portfolio in Q3 2026, its #332 holding.
- Empirical Finance first reported a position in West Pharmaceutical in Q2 2021 and has held it in 22 quarters since.
- Empirical Finance's West Pharmaceutical position peaked at $992K in Q1 2024.
- 875 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Empirical Finance's 13F filing for Q3 2026, filed 13 Nov 2026.